Use and cost comparison of clobazam to other antiepileptic drugs for treatment of Lennox-Gastaut syndrome

• Main Authors: Clément François (Author), John M. Stern (Author), Augustina Ogbonnaya (Author), Tasneem Lokhandwala (Author), Pamela Landsman-Blumberg (Author), Amy Duhig (Author), Vivienne Shen (Author), Robin Tan (Author)
• Format: Book
• Published: Taylor & Francis Group, 2017-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Lennox-Gastaut syndrome (LGS) is a severe form of childhood-onset epilepsy associated with serious injuries due to frequent and severe seizures. Of the antiepileptic drugs (AEDs) approved for LGS, clobazam is a more recent market entrant, having been approved in October 2011. Recent AED...